Affiliation:
1. Immune-Oncological Centre Cologne (IOZK), D-50674 Cologne, Germany
Abstract
The fundamental aim of healthcare is to improve overall health of the population by providing state-of-the-art healthcare for individuals at an affordable cost. The foundation for this system is largely referred to as “evidence-based medicine”. Too often, evidence-based medicine is based solely on so-called “best research evidence”, collected through randomized controlled trials while disregarding clinical expertise and patient expectations. As healthcare gravitates towards personalized and individualized medicine, such external clinical (research) evidence can inform, but never replace, individual clinical expertise. This applies in particular to orphan diseases, for which clinical trials are methodologically particularly problematic, and evidence derived from them is often questionable. Evidence-based medicine constitutes a complex process to allow doctors and patients to select the best possible solutions for each individual based on rapidly developing new therapeutic directions. This requires a revisit of the foundations of evidence-based medicine. A proposition as to how to manage evidence-based data in individualized immune-oncology is presented here.
Funder
Stiftung für immunologisch-onkologische Forschung IOZK gGmbH
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference64 articles.
1. Garg, A. (2023). Methods in Cell Biology, Elsevier.
2. Schirrmacher, V., Sprenger, T., Stuecker, W., and Van Gool, S.W. (2020). Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit. Biomedicines, 8.
3. Huber, F. (2014). Individueller Heilversuch und Klinisches Experiment. [Ph.D. Thesis, Universität Augsburg].
4. Van Gool, S.W., Makalowski, J., Van de Vliet, P., Van Gool, S., Sprenger, T., Schirrmacher, V., and Stuecker, W. (2023). Individualized multimodal immunotherapy for adults with IDH1 wild-type GBM: A single institute experience. Cancers, 15.
5. Schirrmacher, V. (2020). Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis. Biomedicines, 8.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献